Pembro Plus CAR T-cell Therapy in R/R in PMBCL — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pembro Plus CAR T-cell Therapy in R/R in PMBCL — Stella

Recruiting

Back to Primary Mediastinal Large B-cell Lymphoma (PMBCL) trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(2 sites)

United States

Dana-Farber Cancer Institute, Boston, Massachusetts

Memorial Sloan Kettering Cancer Center, New York, New York

Key details

Phase

Safety & dosing

Sponsor

Jennifer Crombie, MD

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~35 participants

Started

November 2023

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov